Loading...

Member Profile

Somnics Inc., a Taiwan based medical device manufacturing company, focuses on developing innovative technologies for the treatment of Obstructive Sleep Apnea (OSA).

The company was founded in 2011 by Dr. Chung-Chu Chen, Dr. Chen himself suffers Sleep Apnea and understands the deficiencies of current products. Its main product iNAP® Sleep Therapy System, that utilizes intra-oral Negative Air Pressure Technology to treat obstructive sleep apnea, as opposed to forced air of CPAP, iNAP® has oral interface worn in patient’s mouth, a quiet pump in the console creates gentle suction in the oral cavity to stabilize the tongue and the soft palate in a forward position, thereby opening up the blocked airway, preventing from sleep apnea.

Our mission is to satisfy unmet needs of patients and physicians. Targeting at deficiencies of other OSA therapies, we provide patient-centered and user-friendly solutions for comfort and restful sleep.

iNAP® Sleep Therapy System is designed to treat Obstructive Sleep Apnea (OSA) in adults. When using iNAP® Sleep Therapy System during sleep, it provides a pressure gradient within the oral cavity and the pressure gradient pulls the tongue toward upper palate and also pulls the soft palate forward.

Contrary to existing OSA-treatment machine that uses Continuous Positive Airway Pressure (CPAP), our product, iNAP® comes with revolutionary therapy system of applying Negative Pressure to oral cavity, provides a simple, more comfortable and discreet way that allows patients to breath naturally during OSA treatment.

The iNAP® Sleep Therapy System is also equipped with App that allows OSA patients to self-monitor their treatment time and sealing time for days, weeks, and adapt themselves to the new medical equipment effectively.


Company Milestones

   2010 Somnics, Inc. founded in Hsinchu
   2012 Awarded ISO 13485 certification
   2013 Awarded Taiwan GMP Certification
   2016 NAP® Awarded iF Design Award & A’Design Award
   2017 Somnics, Inc. approved as a listed company at Taipei Exchange emerging stock market
   2017 iNAP® Lite TFDA approved in Taiwan
   2019 iNAP® One Awarded European Design Award Silver Prize
   2020 Received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for its iNAP® One Sleep Therapy System.